334 related articles for article (PubMed ID: 37958294)
1. Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management.
Elderkin J; Al Hallak N; Azmi AS; Aoun H; Critchfield J; Tobon M; Beal EW
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958294
[TBL] [Abstract][Full Text] [Related]
2. Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study.
Kudo M; Aoki T; Ueshima K; Tsuchiya K; Morita M; Chishina H; Takita M; Hagiwara S; Minami Y; Ida H; Nishida N; Ogawa C; Tomonari T; Nakamura N; Kuroda H; Takebe A; Takeyama Y; Hidaka M; Eguchi S; Chan SL; Kurosaki M; Izumi N
Liver Cancer; 2023 Sep; 12(4):321-338. PubMed ID: 37901197
[TBL] [Abstract][Full Text] [Related]
3. Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review.
Ahmed F; Onwumeh-Okwundu J; Yukselen Z; Endaya Coronel MK; Zaidi M; Guntipalli P; Garimella V; Gudapati S; Mezidor MD; Andrews K; Mouchli M; Shahini E
World J Gastrointest Oncol; 2021 Nov; 13(11):1813-1832. PubMed ID: 34853653
[TBL] [Abstract][Full Text] [Related]
4. Update on the Diagnosis and Treatment of Hepatocellular Carcinoma.
Ferrante ND; Pillai A; Singal AG
Gastroenterol Hepatol (N Y); 2020 Oct; 16(10):506-516. PubMed ID: 34017223
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in multidisciplinary management of hepatocellular carcinoma.
Gomaa AI; Waked I
World J Hepatol; 2015 Apr; 7(4):673-87. PubMed ID: 25866604
[TBL] [Abstract][Full Text] [Related]
6. An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis.
Salhab M; Canelo R
J Cancer Res Ther; 2011; 7(4):463-75. PubMed ID: 22269411
[TBL] [Abstract][Full Text] [Related]
7. Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation.
Katariya NN; Lizaola-Mayo BC; Chascsa DM; Giorgakis E; Aqel BA; Moss AA; Uson Junior PLS; Borad MJ; Mathur AK
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565184
[TBL] [Abstract][Full Text] [Related]
8. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs.
Reggidori N; Bucci L; Santi V; Stefanini B; Lani L; Rampoldi D; Ghittoni G; Farinati F; Masotto A; Stefanini B; Mega A; Biasini E; Foschi FG; Svegliati-Baroni G; Sangiovanni A; Campani C; Raimondo G; Vidili G; Gasbarrini A; Celsa C; Di Marco M; Giannini EG; Sacco R; Brunetto MR; Azzaroli F; Magalotti D; Morisco F; Rapaccini GL; Nardone G; Vitale A; Trevisani F;
JHEP Rep; 2023 Aug; 5(8):100784. PubMed ID: 37520672
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment.
Schütte K; Schulz C; Malfertheiner P
Gastrointest Tumors; 2014 Jun; 1(2):84-92. PubMed ID: 26672483
[TBL] [Abstract][Full Text] [Related]
10. A multidisciplinary approach to the management of hepatocellular carcinoma.
Gish RG; Marrero JA; Benson AB
Gastroenterol Hepatol (N Y); 2010 Mar; 6(3 Suppl 6):1-16. PubMed ID: 20567570
[TBL] [Abstract][Full Text] [Related]
11. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
[TBL] [Abstract][Full Text] [Related]
12. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
Poon RT; Fan ST; Tsang FH; Wong J
Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
[TBL] [Abstract][Full Text] [Related]
13. Management of hepatocellular carcinoma.
Fitzmorris P; Shoreibah M; Anand BS; Singal AK
J Cancer Res Clin Oncol; 2015 May; 141(5):861-76. PubMed ID: 25158999
[TBL] [Abstract][Full Text] [Related]
14. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: natural history, current management, and emerging tools.
Tinkle CL; Haas-Kogan D
Biologics; 2012; 6():207-19. PubMed ID: 22904613
[TBL] [Abstract][Full Text] [Related]
16. Goals and targets for personalized therapy for HCC.
Couri T; Pillai A
Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
[TBL] [Abstract][Full Text] [Related]
17. The importance of a multidisciplinary approach to hepatocellular carcinoma.
Siddique O; Yoo ER; Perumpail RB; Perumpail BJ; Liu A; Cholankeril G; Ahmed A
J Multidiscip Healthc; 2017; 10():95-100. PubMed ID: 28360525
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective.
Su TH; Wu CH; Liu TH; Ho CM; Liu CJ
Clin Mol Hepatol; 2023 Apr; 29(2):230-241. PubMed ID: 36710607
[TBL] [Abstract][Full Text] [Related]
19. Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review.
Lim H; Ramjeesingh R; Liu D; Tam VC; Knox JJ; Card PB; Meyers BM
J Natl Cancer Inst; 2021 Feb; 113(2):123-136. PubMed ID: 32898239
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
